Skip to content
healthcare.dev

VIVJOA

NDC 74695-823, oteseconazole, capsule, from Mycovia Pharmaceuticals, Inc..

Product NDC
74695-823
Status
Listed
Labeler
Mycovia Pharmaceuticals, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215888
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/74695-823 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OTESECONAZOLE150 mg/1

Pharmacologic classes

Azole Antifungal [EPC]; Azoles [CS]; Breast Cancer Resistance Protein Inhibitors [MoA]

Package NDCNDC-11Package
74695-823-18746950823181 CONTAINER in 1 CARTON (74695-823-18) / 1 BLISTER PACK in 1 CONTAINER / 18 CAPSULE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e21d5008-800e-4417-927f-14340341865f

Use it

Look up 74695-823 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/74695-823 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 74695-823. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.